The National Specialised Commissioning Group (NSCAG) was established to commission services on a national basis for a specific group of extremely rare conditions or very unusual treatments. It had been in operation in various guises since 1983. It has now been superseded by the National Commissioning Group (NCG). The NCG advises Ministers on which NHS services are best commissioned nationally, rather than locally, to ensure a high quality of clinical care and equity of access for patients, as well as securing value for money.
Commissioning arrangements for specialised services were strengthened following an independent review led by Sir David Carter; the NSCG, the NCG and new SCGs were established as a result.
Ten new SCGs have been established to commission services on a regional basis. This succeeds mixed arrangements of region-wide and more local commissioning groups. Each new SCG acts on behalf of a population of about five million. Services commissioned at SCG level include haemophilia services and blood & marrow transplantation. The 10 SCGs are now coterminous with the 10 Strategic Health Authorities (SHAs).
The NSCG (initially known as NSSCG but renamed as NSCG in May 2007 for ease of reference) is a completely new advisory body and was established to oversee the national commissioning function and to facilitate collaborative working at a pan-SCG level. The core membership is Chairs of SCGs (PCT Chief Executives) or Directors of SCGs